Reports - Companion Diagnostics Market
HealthcareCompanion Diagnostics Market
Companion Diagnostics Market Valuation and Future Projections to 2035 by Product & Service (Assays, Kits & Reagents, Software & Services) by Technology (Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry, Other Technologies) by Indication (Cancer, Neurological Disorders, Cardiovascular Disorders, Infectious Diseases, Other Indication) by End Users (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Companion Diagnostics Market - Segment Analysis
1. Overview
2. Global Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. Global Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. Global Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. Global Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
7. Global Companion Diagnostics Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Companion Diagnostics Market - Segment Analysis
1. Overview
2. North America Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. North America Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. North America Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. North America Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
Chapter 5 Europe Companion Diagnostics Market - Segment Analysis
1. Overview
2. Europe Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. Europe Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. Europe Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. Europe Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
Chapter 6 Asia Pacific Companion Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. Asia Pacific Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. Asia Pacific Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. Asia Pacific Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
Chapter 7 Latin America Companion Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. Latin America Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. Latin America Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. Latin America Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
Chapter 8 Middle East & Africa Companion Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Companion Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Companion Diagnostics Market - by Product & Service
3.1. By Assays
3.2. By Kits & Reagents
3.3. By Software & Services
4. Middle East & Africa Companion Diagnostics Market - by Technology
4.1. By Next-Generation Sequencing
4.2. By In Situ Hybridization
4.3. By Immunohistochemistry
4.4. By Other Technologies
5. Middle East & Africa Companion Diagnostics Market - by Indication
5.1. By Cancer
5.2. By Neurological Disorders
5.3. By Cardiovascular Disorders
5.4. By Infectious Diseases
5.5. By Other Indication
6. Middle East & Africa Companion Diagnostics Market - by End Users
6.1. By Pharmaceutical & Biopharmaceutical Companies
6.2. By Reference Laboratories
6.3. By Contract Research Organizations
6.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Abbott Laboratories Molecular Inc. (U.S.)
2. Agilent (Dako Denmark A/S) (U.S.)
3. ARUP Laboratories Inc. (U.S.)
4. BioMerieux (France)
5. Danaher Corporation (Leica Microsystems) (Germany)
6. Foundation Medicine Inc. (U.S.)
7. Myriad Genetics Inc. (U.S.)
8. Roche (Ventana Medical Systems Inc.) (U.S.)
9. Thermo Fisher Scientific (Life Technologies Corporation) (Germany)
10. QIAGEN N.V. (Germany)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By